Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription


1 Acta Neurol Scand
1 Am J Kidney Dis
1 Ann Neurol
2 BMC Neurol
5 Diabet Med
2 Intern Med
2 J Autoimmun
1 J Clin Endocrinol Metab
1 J Immunol
2 J Nephrol
2 J Neuroimmunol
1 J Neurol
2 J Pediatr
2 J Pediatr Endocrinol Metab
1 Kidney Int
1 Lancet Neurol
4 Mult Scler
1 N Engl J Med
1 Neurologia (Engl Ed)
5 Neurology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. ZHAO N, Chang SH, Zhang QX, Zhang LJ, et al
    Clinical features of Guillain-Barre syndrome with anti-neurofascin 155 antibody.
    Acta Neurol Scand. 2022;146:553-561.
    PubMed         Abstract available

    Am J Kidney Dis

  2. JAVAUGUE V, Said SM, Bu L, Bridoux F, et al
    Prognostic Value of Diffuse Crescentic Lesions in Fibrillary Glomerulonephritis.
    Am J Kidney Dis. 2022 Oct 10. pii: S0272-6386(22)00927.

    Ann Neurol

  3. MURPHY OC, Sotirchos ES, Kalaitzidis G, Vasileiou E, et al
    Trans-synaptic degeneration following acute optic neuritis in multiple sclerosis.
    Ann Neurol. 2022 Oct 11. doi: 10.1002/ana.26529.
    PubMed         Abstract available

    BMC Neurol

    The utility of diffusion-weighted imaging in patients with spinal cord infarction: difference from the findings of neuromyelitis optica spectrum disorder.
    BMC Neurol. 2022;22:382.
    PubMed         Abstract available

  5. BARZEGAR M, Manteghinejad A, Bagherieh S, Sindarreh S, et al
    Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study.
    BMC Neurol. 2022;22:379.
    PubMed         Abstract available

    Diabet Med

  6. SUGRUE M, Liddy AM, McDermott JH, Sreenan S, et al
    Diabetic Ketoacidosis as a Unique Presentation of Cystic Fibrosis.
    Diabet Med. 2022 Apr 25:e14859. doi: 10.1111/dme.14859.

  7. ITZKOVITZ A, Maggio V, Roy-Fleming A, Legault L, et al
    Nutrition and Food Literacy among Young Canadian Adults Living with Type 1 Diabetes.
    Diabet Med. 2022 Jul 23:e14921. doi: 10.1111/dme.14921.
    PubMed         Abstract available

  8. TANENBAUM ML, Zaharieva DP, Addala A, Prahalad P, et al
    "Much more convenient, just as effective:" Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.
    Diabet Med. 2022 Jul 28:e14923. doi: 10.1111/dme.14923.
    PubMed         Abstract available

  9. DESHMUKH H, Wilmot E, Pieri B, Choudhary P, et al
    Time in Range (TIR) following flash glucose monitoring; relationship with glycaemic control, diabetes-related distress (DRD) and resource utilisation in the Association of British Clinical Diabetologists (ABCD) national audit.
    Diabet Med. 2022 Aug 26:e14942. doi: 10.1111/dme.14942.
    PubMed         Abstract available

  10. BROWN RE, Chu L, Norman GJ, Abitbol A, et al
    Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-C
    Diabet Med. 2022 Aug 18:e14937. doi: 10.1111/dme.14937.
    PubMed         Abstract available

    Intern Med

  11. MURAYAMA A, Sugaya K, Hara M, Kawazoe T, et al
    Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Intern Med. 2022 Oct 12. doi: 10.2169/internalmedicine.9670.
    PubMed         Abstract available

  12. GODA M, Takigawa Y, Fujiwara K, Shinno Y, et al
    Upper Lobe-predominant Autoimmune Pulmonary Alveolar Proteinosis.
    Intern Med. 2022 Oct 12. doi: 10.2169/internalmedicine.0226.

    J Autoimmun

  13. HAKROUSH S, Tampe D, Baier E, Kluge IA, et al
    Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis.
    J Autoimmun. 2022;133:102924.
    PubMed         Abstract available

  14. GERUSSI A, Soskic B, Asselta R, Invernizzi P, et al
    GWAS and autoimmunity: What have we learned and what next.
    J Autoimmun. 2022;133:102922.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  15. O'ROURKE C, Ylescupidez A, Bahnson HT, Bender C, et al
    Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis.
    J Clin Endocrinol Metab. 2022 Oct 13. pii: 6759855. doi: 10.1210.
    PubMed         Abstract available

    J Immunol

  16. LU Y, Xu M, Dorrier CE, Zhang R, et al
    CD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells.
    J Immunol. 2022 Oct 12. pii: jimmunol.2200439. doi: 10.4049/jimmunol.2200439.
    PubMed         Abstract available

    J Nephrol

  17. DE SOUZA L, Ismail I, Baade R, Mantha M, et al
    Lessons for the clinical nephrologist: dialysis decisions in early pregnancy for acute kidney injury due to post-infectious glomerulonephritis (PIGN).
    J Nephrol. 2022 Oct 14. pii: 10.1007/s40620-022-01464.

  18. CHBIHI M, Eveillard LA, Riller Q, Brousse R, et al
    Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
    J Nephrol. 2022 Oct 8. pii: 10.1007/s40620-022-01438.
    PubMed         Abstract available

    J Neuroimmunol

  19. VERGOOSSEN DLE, Ruiter AM, Keene KR, Niks EH, et al
    Enrichment of serum IgG4 in MuSK myasthenia gravis patients.
    J Neuroimmunol. 2022;373:577978.
    PubMed         Abstract available

  20. FARAJI J, Gustafson C, Bettenson D, Negoro H, et al
    Bladder dysfunction in experimental autoimmune encephalomyelitis reflects clinical severity: A pilot study.
    J Neuroimmunol. 2022;372:577973.
    PubMed         Abstract available

    J Neurol

  21. STRANO CMM, Sorrenti B, Bosco L, Falzone YM, et al
    Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report.
    J Neurol. 2022;269:6152-6154.

    J Pediatr

  22. ASHKENAZI L, Hashkes PJ
    50 Years Ago in TheJournalofPediatrics: Isolated Rheumatoid-Like Nodules with Positive Rheumatoid Factor in Childhood Is Not a Harbinger for Juvenile Idiopathic Arthritis.
    J Pediatr. 2022;249:49.

  23. ASHKENAZI L, Hashkes PJ
    50 Years Ago in TheJournalofPediatrics: Immunodeficiency and Autoimmunity-Are There Common Pathways?
    J Pediatr. 2022;249:58.

    J Pediatr Endocrinol Metab

  24. LOOMBA LA, Hughes Lansing A, Cortez JN, Welch K, et al
    Parental marital relationship satisfaction predicts glycemic outcomes in children with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2022;35:1293-1297.
    PubMed         Abstract available

  25. RAJASEGARAN VP, Tamilarasan P, Kalaimani T
    Diabetic ketoacidosis masquerading behind alkalemia an undiagnosed or missed variant of diabetic ketoacidosis.
    J Pediatr Endocrinol Metab. 2022;35:1316-1318.
    PubMed         Abstract available

    Kidney Int

  26. HOXHA E, Reinhard L, Castedello T, Becker JU, et al
    False positivity for PLA2R1-antibody measured by ELISA in a nephrotic patient with no membranous nephropathy.
    Kidney Int. 2022 Oct 5. pii: S0085-2538(22)00807.

    Lancet Neurol

  27. GRAVES JS, Krysko KM, Hua LH, Absinta M, et al
    Ageing and multiple sclerosis.
    Lancet Neurol. 2022 Oct 7. pii: S1474-4422(22)00184.
    PubMed         Abstract available

    Mult Scler

  28. KATZ SAND I, Levy S, Fitzgerald K, Sorets T, et al
    Mediterranean diet is linked to less objective disability in multiple sclerosis.
    Mult Scler. 2022 Oct 13:13524585221127414. doi: 10.1177/13524585221127414.
    PubMed         Abstract available

  29. HANCOCK LM, Galioto R, Samsonov A, Busch RM, et al
    A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS).
    Mult Scler. 2022 Oct 14:13524585221127941. doi: 10.1177/13524585221127941.
    PubMed         Abstract available

  30. BOURDETTE D, Herink M
    Polypharmacy in multiple sclerosis: More is not necessarily better.
    Mult Scler. 2022 Oct 14:13524585221129964. doi: 10.1177/13524585221129964.

  31. ECTRIMS 2022 Committees.
    Mult Scler. 2022;28.

    N Engl J Med

  32. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.

    Neurologia (Engl Ed)

  33. VISCASILLAS SANCHO M, Moreno Loscertales C, Garcia Rubio S, Sagarra Mur D, et al
    Hashimoto encephalopathy after vaccination against SARS-CoV-2.
    Neurologia (Engl Ed). 2022 Oct 11. pii: S2173-5808(22)00135.


  34. KUANG SY, Li Y, Yang SL, Han X, et al
    Child Neurology: Aicardi-Goutieres Syndrome Presenting as Recurrent Ischemic Stroke.
    Neurology. 2022 Jul 8. pii: WNL.0000000000200952.
    PubMed         Abstract available

  35. COTE-OROZCO JE, Velez-Tirado N
    Teaching NeuroImage: Hypothalamic Involvement in Neuromyelitis Optica Spectrum Disorder in a Child.
    Neurology. 2022;99:535-536.

  36. JEANTIN L, Plu I, Amador MDM, Maillart E, et al
    Pearls & Oy-sters: Spinal Cord Candidiasis Linked to CARD9 Deficiency Masquerading as a Longitudinally Extensive Transverse Myelitis.
    Neurology. 2022;99:475-479.
    PubMed         Abstract available

  37. SHAH SS, Morris P, Buciuc M, Tajfirouz D, et al
    Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD.
    Neurology. 2022;99:e851-e857.
    PubMed         Abstract available

  38. MURPHY OC, Calabresi PA, Gold DR
    Teaching Video NeuroImage: Dramatic Response to Topiramate in Acquired Pendular Nystagmus From Multiple Sclerosis.
    Neurology. 2022 Oct 11. pii: WNL.0000000000201452.

    PLoS One

  39. GUIMARAES JAR, Furtado SDC, Lucas ACDS, Mori B, et al
    Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
    PLoS One. 2022;17:e0275016.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.